Safety of Alemtuzumab and Autologous HSCT Compared With Noninduction Therapies for MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety of Alemtuzumab and Autologous Hematopoietic Stem Cell Transplantation Compared to Noninduction Therapies for Multiple Sclerosis
Neurology 2021 Mar 16;96(11)e1574-e1584, P Alping, J Burman, J Lycke, T Frisell, F PiehlFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.